Analysis of Outcomes Using Low-Dose and Early Administration of Recombinant Activated Factor VII in Cardiac Surgery Jason Brase, MS, Brooke Finger, MS,

Slides:

Advertisements

Similar presentations

Changes in Risk Profile Over Time in the Population of a Pediatric Heart Transplant Program Olaf Reinhartz, MD, Katsuhide Maeda, MD, Bruce A. Reitz, MD,

Advertisements

Obese Patients and Mechanical Circulatory Support: Weight Loss, Adverse Events, and Outcomes Firas Zahr, MD, Elizabeth Genovese, MS, Michael Mathier,

Elevated Hemoglobin A1c Is Associated With Lower Socioeconomic Position and Increased Postoperative Infections and Longer Hospital Stay After Cardiac.

Giant Transdiaphragmatic Intercostal Hernia

Elevated Hemoglobin A1c Is Associated With Lower Socioeconomic Position and Increased Postoperative Infections and Longer Hospital Stay After Cardiac.

Clinical Outcomes in Patients With Prolonged Intensive Care Unit Length of Stay After Cardiac Surgical Procedures Ansar Hassan, MD, PhD, Curtis Anderson,

Reply The Annals of Thoracic Surgery

Outcomes of Reintervention on the Autograft After Ross Procedure

Risk-Adjusted Prolonged Length of Stay as an Alternative Outcome Measure for Pediatric Congenital Cardiac Surgery Ming Liu, MS, MA, Charlotte M. Druschel,

Association of Perioperative Fluid Balance and Adverse Surgical Outcomes in Esophageal Cancer and Esophagogastric Junction Cancer Shenhai Wei, MD, PhD,

Robert L. Smith, MD, Morley A. Herbert, PhD, Todd M

Differential Distribution of Lipid Microemboli After Cardiac Surgery

Recombinant Activated Factor VII in Cardiac Surgery: Experience From the Australian and New Zealand Haemostasis Registry Scott Dunkley, BMed, FRACP,

Hyde M. Russell, MD, Soraya L. Johnson, BS, Katherine C

Platelet Transfusion in Cardiac Surgery Does Not Confer Increased Risk for Adverse Morbid Outcomes Tory McGrath, MD, Colleen Gorman Koch, MD, MS, Meng.

Richard K. Freeman, MD, Anthony J. Ascioti, MD, Jaclyn M

Age of Transfused Red Cells and Early Outcomes After Cardiac Surgery

The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis Naoto Morimoto,

Obese Patients and Mechanical Circulatory Support: Weight Loss, Adverse Events, and Outcomes Firas Zahr, MD, Elizabeth Genovese, MS, Michael Mathier,

Anomalous Great Cardiac Vein Draining Into the Superior Vena Cava

K. Robert Shen, MD, Mark S. Allen, MD, Stephen D

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Mark D. Iannettoni, MD, William R. Lynch, MD, Kalpaj R

FDA Perspective on Clinical Trial Design for Cardiovascular Devices

Surgical Resection of a Giant Coronary Aneurysm

Susanne Lison, MD, Michael Spannagl, MD, PhD, Wulf Dietrich, MD, PhD

Pleural Metastasis of Osteosarcoma

Surgical Repair of a Chronic Traumatic Sternal Fracture

Successful Use of Recombinant Activated Coagulation Factor VII in a Patient with Massive Hemoptysis From a Penetrating Thoracic Injury Homer C.N. Tien,

Dissecting Multidisciplinary Cardiac Surgery Rounds

Origins of the Cardiothoracic Surgery Network (CTSNet)

Who Do You Say You Are? The Annals of Thoracic Surgery

Outcomes of Mechanical Valves in the Pulmonic Position in Patients With Congenital Heart Disease Over a 20-Year Period Hong Ju Shin, MD, Young-Hwue Kim,

Early Extubation Without Increased Adverse Events in High-Risk Cardiac Surgical Patients Brigid C. Flynn, MD, Jianghua He, PhD, Matthew Richey, MD, Katy.

Use of Amiodarone After Major Lung Resection

Surgical Dilemmas: Diagnosis and Treatment of Atrial Plasmacytoma

Kuthan Kavakli, MD, Deniz Dogan, MD, Sedat Gurkok

Impact of Blood Product Transfusion on Short and Long-Term Survival After Cardiac Surgery: More Evidence Balu Bhaskar, MD, FCICM, Joel Dulhunty, PhD,

Joseph Rabin, MD, Timothy Meyenburg, DNP, CRNP, Ashleigh V

Kathryn E. Engelhardt, MD, Malcolm M. DeCamp, MD, Anthony D

Is Nocturnal Extubation After Cardiac Surgery Associated With Worse Outcomes? Murtaza Diwan, MD, Jeremy Wolverton, MS, Bo Yang, MD, Jonathan Haft, MD,

Embolized Methyl Methacrylate to the Right Atrium After Kyphoplasty

Michael J. Wolf, MD, Kirk R. Kanter, MD, Paul M. Kirshbom, MD, Brian E

Editorial Board, January 2010

Bradford B. Smith, MD, Matthew A

Sarah C. Huen, MD, Chirag R. Parikh, MD, PhD

Severe Two-Vessel Ostial Stenosis of the Main Coronary Arteries in a Patient With Transposition of the Great Arteries After an Arterial Switch Operation

Completely Thrombosed Tricuspid Pouch Mimicking a Cardiac Tumor

Roni M. Jacobsen, MD, Michael G. Earing, MD, Garick D

A. Thomas Pezzella, MD, Sari D

Late Postpneumonectomy Death From Stump Thrombus

Limitations of Hospital Volume as a Measure of Quality of Care for Coronary Artery Bypass Graft Surgery Karl F. Welke, MD, Mitchell J. Barnett, PharmD,

Anirudh Vinnakota, MS, Robert Stewart, MD, Gosta Pettersson, MD, PhD

Mediastinitis After More Than 10,000 Cardiac Surgical Procedures

L. Wiley Nifong, MD, Evelio Rodriguez, MD, W. Randolph Chitwood, MD

Specialty Training and Mortality After Esophageal Cancer Resection

Very Prolonged Stay in the Intensive Care Unit After Cardiac Operations: Early Results and Late Survival Shuli Silberman, MD, Daniel Bitran, MD, Daniel.

Contemporary Outcomes of Surgical Repair of Total Anomalous Pulmonary Venous Connection in Patients With Heterotaxy Syndrome Muhammad S. Khan, MD, Roosevelt.

Cost-Effectiveness of Mitral Valve Repair Versus Replacement by Biologic or Mechanical Prosthesis Ariel Beresniak, MD, PhD, Brigitte Sabatier, PharmD,

Dana Y. Fuhrman, DO, MS, Lan G

Invited Commentary The Annals of Thoracic Surgery

Recombinant Activated Factor VII in Cardiac Surgery: A Systematic Review Oliver Warren, MRCS, Kaushik Mandal, MS, MRCS, Vassilis Hadjianastassiou, MD,

Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization Paul Kurlansky, MD, Morley Herbert, PhD, Syma.

“Transitions” for Cardiothoracic Surgeons Now Listed on the Web:

Experience With Bovine Pericardium for the Reconstruction of the Aortic Arch in Patients Undergoing a Norwood Procedure Victor O. Morell, MD, Peter A.

Late Consequences of a Much Earlier Decision

Aortic Valve Replacement Surgery: Comparison of Outcomes in Matched Sternotomy and PORT ACCESS Groups William T. Brinkman, MD, William Hoffman, MD, Todd.

The Impact of New Technology on Cardiothoracic Surgical Practice

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Hari Padmanabhan, MRCP, Matthew J. Brookes, PhD, Alan M

Presentation transcript:

Analysis of Outcomes Using Low-Dose and Early Administration of Recombinant Activated Factor VII in Cardiac Surgery Jason Brase, MS, Brooke Finger, MS, Jianghua He, PhD, Katy Wirtz, RN, BSN, Lucy Stun, PharmD, Randy McMillen, Brigid Flynn, MD The Annals of Thoracic Surgery Volume 102, Issue 1, Pages 35-40 (July 2016) DOI: 10.1016/j.athoracsur.2016.01.004 Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Concomitant blood product administration in patients who received recombinant activated factor VII (n = 51). The Annals of Thoracic Surgery 2016 102, 35-40DOI: (10.1016/j.athoracsur.2016.01.004) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Total number of cardiac surgical study patients who had bleeding by definition (n = 378). Fifty-one (13%) patients who bled received recombinant activated factor VII (rFVIIa) with a nonprotocolized, liberal strategy of rFVIIa administration. The Annals of Thoracic Surgery 2016 102, 35-40DOI: (10.1016/j.athoracsur.2016.01.004) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions